4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000950170-25-042728
Chief Medical Officer sold 45,316 shares at $8.76 ($396,995)
- Chief Medical Officer acquired 18,489 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nichols William Garrett Chief Medical Officer | 2025-03-18 | Option exercise 10b5-1 | +4,584 | $3.75 | $17,190 | 83,904 | D |
| Nichols William Garrett Chief Medical Officer | 2025-03-18 | Option exercise 10b5-1 | +13,905 | $1.29 | $17,937 | 97,809 | D |
| Nichols William Garrett Chief Medical Officer | 2025-03-18 | Sale 10b5-1 | −45,316 | $8.76 | $396,995 | 52,493 | D |
| Derivatives | |||||||
| Nichols William Garrett Chief Medical Officer | 2025-03-18 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,584 | 195,416 | D | ||
| Nichols William Garrett Chief Medical Officer | 2025-03-18 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −13,905 | 31,095 | D | ||
| Open-market sales · 45,316 sh · avg $8.76 · $396,995 | |||||||
Loading xslF345X05/ownership.xml…